Skip to content
Search

Latest Stories

Hospices receive £25 million for facility upgrades and refurbishments

An additional £75 million will be allocated from April to support major building works and facility modernisation

Hospices receive £25 million for facility upgrades and refurbishments

The finding will help reform the palliative and end of life care system

gettyimages


The government has confirmed the release of £25 million for upgrades and refurbishments for hospices across England, as part of the biggest investment into hospices in a generation.


More than 170 hospices across the country will receive funding, including those run by Marie Curie and Sue Ryder, as well as independent hospices like Zoe’s Place in Liverpool, to improve end-of-life care services across England.

They will begin receiving the cash from today (26) for the 2024/25 financial year, with a further £75 million to follow from April.

This investment forms a key part of the government’s Plan for Change, improving care in the community where people need it most.

“This is the largest investment in a generation to help transform hospice facilities across England,” said health minister Stephen Kinnock.

“From upgrading patient rooms to improving gardens and outdoor spaces, this funding will make a real difference to people at the end of their lives.

“Hospices provide invaluable care and support when people need it most and this funding boost will ensure they are able to continue delivering exceptional care in better, modernised facilities,” he added.

Allocated through Hospice UK from the department, the immediate cash injection will enable hospices to purchase essential new medical equipment, undertake building refurbishments, improve technology, upgrade facilities for patients and families and implement energy efficiency measures.

The larger £75 million investment will support more substantial capital projects, including major building works and facility modernisation, throughout the next financial year.

Toby Porter, CEO of Hospice UK, said: “The announcement before Christmas of £100m of additional funding for hospices in England was a significant boost, and today’s news of the allocation of the first £25m of this funding will be a huge relief for our members.”

He pointed out that years of rapidly rising costs have limited hospices' ability to invest in their long-term infrastructure, noting that this additional support will help address that challenge while also relieving the immediate pressures on hospice finances.

“The greater stability provided by the government’s funding injection this year and next gives us a golden opportunity to now reform the palliative and end of life care system, so it’s fit for the future,” Porter stated.

A key focus of the investment will be digital transformation, enabling hospices to modernise their IT systems and improve data sharing between healthcare providers.

The funding will also support the development of outreach services, allowing hospices to extend their care beyond their physical buildings. This includes investing in mobile equipment and technology that will help support people who wish to receive end-of-life care in their own homes.

More For You

NHS England chief Amanda Pritchard steps down

Amanda Pritchard

REUTERS

NHS England chief Amanda Pritchard steps down, Sir James Mackey named successor

Amanda Pritchard has announced her decision to stand down as chief executive of NHS England at the end of this financial year.

Pritchard, who has led NHS England since August 2021, made history as the first woman to hold the post, playing a pivotal role in steering the NHS through the Covid-19 pandemic. Previously, she served as chief operating officer from 2019.

Keep ReadingShow less
India Cracks Down on Unapproved Tapentadol-Carisoprodol Drug Exports

Tapentadol and carisoprodol combinations are potentially dangerous drugs

gettyimages

India bans export of unapproved tapentadol-carisoprodol drugs

The Union Health Ministry has taken immediate actionagainst a Mumbai-based pharmaceutical manufacturerfollowing reports of unapproved drug combinations containing Tapentadol and Carisoprodol being exported to certain West African countries.

Although Tapentadol and Carisoprodol are individually approved by Central Drugs Standard Control Organization (CDSCO) in India, their combination has not yet received approval.

Keep ReadingShow less
Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

This follows a CMA study on infant formula and follow-on milks, which found that a combination of factors was leading to poor outcomes for parents.

Keep ReadingShow less
CPCF negotiations: CPE working to secure the best outcomes for the sector
Pharmacy sector demands urgent resolution of CPCF negotiations (gettyimages)

CPCF Negotiations: CPE unable to share details until official announcement

Acknowledging the sector's urgent need to resolve CPCF negotiations, CPE reiterates its commitment to securing the best possible outcome

Community Pharmacy England (CPE) has provided an update on the ongoing 2024/25 and 2025/26 Community Pharmacy Contractual Framework (CPCF) negotiations with the Department of Health and Social Care (DHSC) and NHS England.

“The Negotiating Team are continuing in-depth negotiations with DHSC and NHS England,” the Committee said, adding that they are focused on securing the “best outcomes” for pharmacy owners.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less